Examining motor imagery and cognitive functions in people with Type 2 Diabetes
Official title: Relationship Between Motor Imagery Ability, Body Awareness and Cognitive Functions in Individuals With Type 2 Diabetes Mellitus
Run by Kutahya Health Sciences University · NCT06588894 · Data updated 2026-11-12
This study tests how well people with Type 2 Diabetes can imagine movements and how that relates to their thinking skills and body awareness.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Kutahya Health Sciences University Academic / other |
| Locations | 1 site (Kütahya, Central) |
| Status | Recruiting |
| Started | October 14, 2024 |
| Main results expected | November 14, 2026 |
| Study ends | December 10, 2026 |
| Registry record updated | March 10, 2026 |
| Trial ID | NCT06588894 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 18-65 with Type 2 Diabetes Mellitus for at least 5 years.
✕Probably not a fit
Patients with prior experience in motor imagery techniques or those with neurological diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the relationship between motor imagery ability, body awareness, and cognitive functions in individuals diagnosed with Type 2 Diabetes Mellitus. It focuses on how cognitive impairments related to diabetes may affect the ability to create accurate mental images of motor movements. Participants will undergo assessments through questionnaires and physical exams to evaluate their motor imagery skills and body awareness. The findings aim to provide insights into the cognitive motor processes in diabetic patients, potentially guiding future therapeutic approaches.
Why it matters
Potential benefit: If successful, this study could enhance understanding of cognitive impairments in Type 2 Diabetes and inform targeted rehabilitation strategies.
How similar studies have gone: While studies have explored motor imagery in other neurological conditions, this specific focus on Type 2 Diabetes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being a type 2 DM patient between the ages of 18-65 for at least 5 years, * Being willing to participate in the study, * Not having any vision, hearing or speech problems that would prevent the tests from being performed. Exclusion Criteria: * Having previous experience with Motor Imagery techniques or training, * Having any orthopedic problems that prevent walking, * Having a history of neurological disease, * People who are receiving any medication that affects the central nervous system will not be included in the study.
Where it's running
-
Kutahya Health Sciences University
Kütahya, Central, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: İsmail Okur, PhD — Kutahya Health Sciences University
- Study coordinator: İsmail Okur, Assit. Prof.
- Email: ismail.okur@ksbu.edu.tr
- Phone: +905552436726
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lifestyle change program to help type 2 diabetes go into remission in Pakistan
This study tests whether a structured, plant-predominant lifestyle program can put adults with type 2 diabetes in Lahore, Pakistan into remission for the first six months.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
MWN105 injection in overweight or obese adults you may join
This early-phase trial tests whether MWN105 is safe and tolerable in overweight or obese adults in China, using a placebo comparison.
-
MWN109 tablets in adults with type 2 diabetes mellitus
A phase 2 trial tests MWN109 tablets versus placebo (and against active control semaglutide) to see if the medicine helps adults with type 2 diabetes lower their blood sugar.
-
Omega-3 Fatty Acids and Red Blood Cell Membranes in Competitive Soccer Players
This study tests whether high-dose omega-3 supplements change red blood cell membranes and may affect performance and cognition in competitive male soccer players aged 16–35.
-
Brain-heart axis in adults with type 2 diabetes
This study tests how brain activity and heart regulation relate to metabolic status in adults with type 2 diabetes to understand cognitive and functional health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.